These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 15297428)
1. In vitro combination treatment with perifosine and UCN-01 demonstrates synergism against prostate (PC-3) and lung (A549) epithelial adenocarcinoma cell lines. Dasmahapatra GP; Didolkar P; Alley MC; Ghosh S; Sausville EA; Roy KK Clin Cancer Res; 2004 Aug; 10(15):5242-52. PubMed ID: 15297428 [TBL] [Abstract][Full Text] [Related]
2. The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma. Kumar A; Fillmore HL; Kadian R; Broaddus WC; Tye GW; Van Meter TE Mol Cancer Res; 2009 Nov; 7(11):1813-21. PubMed ID: 19887560 [TBL] [Abstract][Full Text] [Related]
3. Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptors. David E; Sinha R; Chen J; Sun SY; Kaufman JL; Lonial S Clin Cancer Res; 2008 Aug; 14(16):5090-8. PubMed ID: 18698026 [TBL] [Abstract][Full Text] [Related]
4. Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. Rahmani M; Reese E; Dai Y; Bauer C; Payne SG; Dent P; Spiegel S; Grant S Cancer Res; 2005 Mar; 65(6):2422-32. PubMed ID: 15781658 [TBL] [Abstract][Full Text] [Related]
5. Pharmacodynamic markers of perifosine efficacy. Hennessy BT; Lu Y; Poradosu E; Yu Q; Yu S; Hall H; Carey MS; Ravoori M; Gonzalez-Angulo AM; Birch R; Henderson IC; Kundra V; Mills GB Clin Cancer Res; 2007 Dec; 13(24):7421-31. PubMed ID: 18094426 [TBL] [Abstract][Full Text] [Related]
6. The farnesyltransferase inhibitor L744832 potentiates UCN-01-induced apoptosis in human multiple myeloma cells. Pei XY; Dai Y; Rahmani M; Li W; Dent P; Grant S Clin Cancer Res; 2005 Jun; 11(12):4589-600. PubMed ID: 15958645 [TBL] [Abstract][Full Text] [Related]
7. Combination treatment of prostate cancer cell lines with bioactive soy isoflavones and perifosine causes increased growth arrest and/or apoptosis. Vinall RL; Hwa K; Ghosh P; Pan CX; Lara PN; de Vere White RW Clin Cancer Res; 2007 Oct; 13(20):6204-16. PubMed ID: 17947488 [TBL] [Abstract][Full Text] [Related]
8. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation. Engel JB; Honig A; Schönhals T; Weidler C; Häusler S; Krockenberger M; Grunewald TG; Dombrowski Y; Rieger L; Dietl J; Wischhusen J Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514 [TBL] [Abstract][Full Text] [Related]
9. Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts. Locatelli SL; Giacomini A; Guidetti A; Cleris L; Mortarini R; Anichini A; Gianni AM; Carlo-Stella C Leukemia; 2013 Aug; 27(8):1677-87. PubMed ID: 23360848 [TBL] [Abstract][Full Text] [Related]
10. Cell cycle-dependent potentiation of cisplatin by UCN-01 in non-small-cell lung carcinoma. Mack PC; Gandara DR; Lau AH; Lara PN; Edelman MJ; Gumerlock PH Cancer Chemother Pharmacol; 2003 Apr; 51(4):337-48. PubMed ID: 12721762 [TBL] [Abstract][Full Text] [Related]
11. Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells. Papa V; Tazzari PL; Chiarini F; Cappellini A; Ricci F; Billi AM; Evangelisti C; Ottaviani E; Martinelli G; Testoni N; McCubrey JA; Martelli AM Leukemia; 2008 Jan; 22(1):147-60. PubMed ID: 17928881 [TBL] [Abstract][Full Text] [Related]
12. Enhancement of antitumor activity of the anti-EGF receptor monoclonal antibody cetuximab/C225 by perifosine in PTEN-deficient cancer cells. Li X; Luwor R; Lu Y; Liang K; Fan Z Oncogene; 2006 Jan; 25(4):525-35. PubMed ID: 16170346 [TBL] [Abstract][Full Text] [Related]
13. RB status as a determinant of response to UCN-01 in non-small cell lung carcinoma. Mack PC; Gandara DR; Bowen C; Edelman MJ; Paglieroni T; Schnier JB; Gelmann EP; Gumerlock PH Clin Cancer Res; 1999 Sep; 5(9):2596-604. PubMed ID: 10499638 [TBL] [Abstract][Full Text] [Related]
14. Perifosine and ABT-737 synergistically inhibit lung cancer cells in vitro and in vivo. Shen J; Xu L; Zhao Q Biochem Biophys Res Commun; 2016 May; 473(4):1170-1176. PubMed ID: 27073162 [TBL] [Abstract][Full Text] [Related]
15. Radiosensitization of squamous cell carcinoma by the alkylphospholipid perifosine in cell culture and xenografts. Vink SR; Lagerwerf S; Mesman E; Schellens JH; Begg AC; van Blitterswijk WJ; Verheij M Clin Cancer Res; 2006 Mar; 12(5):1615-22. PubMed ID: 16533789 [TBL] [Abstract][Full Text] [Related]
16. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo. Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432 [TBL] [Abstract][Full Text] [Related]
17. Phase I study of UCN-01 and perifosine in patients with relapsed and refractory acute leukemias and high-risk myelodysplastic syndrome. Gojo I; Perl A; Luger S; Baer MR; Norsworthy KJ; Bauer KS; Tidwell M; Fleckinger S; Carroll M; Sausville EA Invest New Drugs; 2013 Oct; 31(5):1217-27. PubMed ID: 23443507 [TBL] [Abstract][Full Text] [Related]
18. Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms. Senderowicz AM Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S61-73. PubMed ID: 12819936 [TBL] [Abstract][Full Text] [Related]
19. The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Chiarini F; Del Sole M; Mongiorgi S; Gaboardi GC; Cappellini A; Mantovani I; Follo MY; McCubrey JA; Martelli AM Leukemia; 2008 Jun; 22(6):1106-16. PubMed ID: 18385752 [TBL] [Abstract][Full Text] [Related]
20. Akt down-modulation induces apoptosis of human prostate cancer cells and synergizes with EGFR tyrosine kinase inhibitors. Festuccia C; Gravina GL; Muzi P; Millimaggi D; Dolo V; Vicentini C; Bologna M Prostate; 2008 Jun; 68(9):965-74. PubMed ID: 18361408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]